CPT® Code 90708

Deleted

1. Indications

The measles and rubella virus vaccine (CPT® Code 90708) is indicated for the prevention of measles and rubella infections. These diseases can lead to serious health complications, including pneumonia, encephalitis, and congenital rubella syndrome, which can affect fetal development during pregnancy. Vaccination is crucial in controlling outbreaks and ensuring community immunity, particularly in populations at risk, such as infants and individuals who have not been previously vaccinated.

• Measles Prevention The vaccine is administered to prevent measles, a highly contagious viral infection characterized by fever, cough, runny nose, and a distinctive rash.
• Rubella Prevention The vaccine also protects against rubella, which can cause mild illness in children but can lead to severe birth defects if contracted by pregnant women.

2. Procedure

The administration of the measles and rubella virus vaccine involves several key procedural steps to ensure safety and efficacy. First, the healthcare provider prepares the vaccine by checking the expiration date and ensuring that it has been stored correctly. The vaccine is typically supplied in a vial and must be reconstituted with a diluent if it is in a lyophilized form. Once prepared, the provider selects an appropriate site for subcutaneous injection, usually the outer aspect of the upper arm or the thigh in infants. The skin at the injection site is cleaned with an antiseptic wipe to minimize the risk of infection. The provider then uses a sterile syringe and needle to draw up the vaccine, ensuring that no air bubbles are present in the syringe. The needle is inserted at a 45-degree angle into the subcutaneous tissue, and the vaccine is injected slowly. After the injection, the provider may apply gentle pressure to the site with a cotton ball or gauze and may cover it with a bandage if necessary. Finally, the provider documents the administration of the vaccine in the patient's medical record, including the date, vaccine lot number, and site of injection.

• Step 1: Vaccine Preparation The healthcare provider checks the expiration date and prepares the vaccine, ensuring proper storage and reconstitution if necessary.
• Step 2: Site Selection An appropriate site for subcutaneous injection is selected, typically the outer aspect of the upper arm or thigh.
• Step 3: Skin Cleansing The injection site is cleaned with an antiseptic wipe to reduce the risk of infection.
• Step 4: Injection The vaccine is drawn into a sterile syringe, and the needle is inserted at a 45-degree angle into the subcutaneous tissue for injection.
• Step 5: Post-Injection Care Gentle pressure is applied to the injection site, and documentation of the vaccine administration is completed in the patient's medical record.

3. Post-Procedure

After the administration of the measles and rubella virus vaccine, patients are typically monitored for a short period to observe for any immediate adverse reactions, such as allergic responses. Common side effects may include mild fever, rash, or soreness at the injection site, which usually resolve on their own. Patients are advised to report any unusual symptoms or severe reactions to their healthcare provider. It is also important for patients to receive information regarding the timing of follow-up vaccinations, as the measles and rubella vaccine is often part of a combination vaccine schedule. Documentation of the vaccination should be maintained in the patient's health records to ensure proper tracking of immunization status.